藥店股大漲!零售藥店可憑定點醫療機構開具的電子外配處方銷售藥品
格隆匯1月12日丨大參林、健之佳、益豐藥房漲停,老百姓漲近9%,一心堂漲超7%。國家醫保局昨日正式發佈《零售藥店醫療保障定點管理暫行辦法》和《醫療機構醫療保障定點管理暫行辦法》,其中指出,定點零售藥店可憑定點醫療機構開具的電子外配處方銷售藥品。雖然這不意味着醫保允許和支持網售處方藥。但國家醫保局明確,處方流轉與網售處方藥並不能等同。目前辦法中規範的是符合規定的處方可以流轉到實體藥店取藥或由實體藥店配送的模式,而網售處方藥的有關政策則需要有關主管部門研究明確。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.